Adage Capital Partners’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110M | Buy |
8,403,000
+1,449,000
| +21% | +$19M | 0.19% | 105 |
|
|
2025
Q1 | $100M | Buy |
6,954,000
+1,834,973
| +36% | +$26.4M | 0.19% | 112 |
|
|
2024
Q4 | $85.7M | Buy |
5,119,027
+924,027
| +22% | +$15.5M | 0.15% | 127 |
|
|
2024
Q3 | $67.1M | Buy |
4,195,000
+1,070,000
| +34% | +$17.1M | 0.12% | 184 |
|
|
2024
Q2 | $28.2M | Buy |
3,125,000
+875,000
| +39% | +$7.9M | 0.05% | 355 |
|
|
2024
Q1 | $25.4M | Sell |
2,250,000
-646,128
| -22% | -$7.3M | 0.05% | 388 |
|
|
2023
Q4 | $23.1M | Buy |
2,896,128
+65,628
| +2% | +$522K | 0.05% | 386 |
|
|
2023
Q3 | $18.3M | Buy |
2,830,500
+580,500
| +26% | +$3.76M | 0.04% | 417 |
|
|
2023
Q2 | $13.9M | Buy |
+2,250,000
| New | +$13.9M | 0.03% | 498 |
|